Central Nervous System Memory Impairment

Table of Contents

Memory Impairment Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Memory Impairment Projects
--Allon Therapeutics Inc.
--Accera, Inc.
--AstraZeneca Plc
--Amarin Corporation plc
--Eli Lilly & Co
--Cephalon Inc
--Inflazyme Pharmaceuticals Ltd.
--Helicon Therapeutics, Inc
--Lexicon Pharmaceuticals, Inc
--Ipsen Ltd
--Pharmos Corporation
--Memory Pharmaceuticals Corp
--SERVIER
--Saegis Pharmaceuticals, Inc.
--Targacept Inc
--Symphony Icon, Inc.

--Top Companies in early stage Memory Impairment Projects
--Amarin Corporation plc
--Abbott Laboratories
--Avera Pharmaceuticals, Inc.
--AstraZeneca Plc
--DrugAbuse Sciences, Inc.
--BTG plc
--EPIX Pharmaceuticals Inc
--Eli Lilly & Co
--Helicon Therapeutics, Inc
--Esteve
--Mimetogen Pharmaceuticals Inc.
--Krenitsky Pharmaceuticals Inc.
--Pharmaxon
--Nyxis Neurotherapies, Inc.
--Roche Holdings Ltd
--Proteome Systems Limited
--Targacept Inc
--Suven Life Sciences Limited
--Xytis, Inc.
--Vasogen Inc

Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View